Literature DB >> 9135615

Long-term management of hypercalcaemia in chronically active sarcoidosis.

R N Sinha1, W D Fraser, I F Casson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9135615      PMCID： PMC1296182          DOI： 10.1177/014107689709000311

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  5 in total

1.  Serum angiotensin-converting enzyme activity. Its use in the evaluation and management of hypercalcemia associated with sarcoidosis.

Authors:  R A DeRemee; E G Lufkin; M S Rohrbach
Journal:  Arch Intern Med       Date:  1985-04

2.  Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

Authors:  N H Bell; P H Stern; E Pantzer; T K Sinha; H F DeLuca
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

3.  Hypercalcaemia due to sarcoidosis corrects with bisphosphonate treatment.

Authors:  C J Gibbs; M Peacock
Journal:  Postgrad Med J       Date:  1986-10       Impact factor: 2.401

4.  Sarcoidosis with hypercalcemia--successful treatment of renal insufficiency and renal calcification with prednisolone.

Authors:  Y Rikitake; Y Kinoshita; Y Kotani; C Kawanami; M Asahara; Y Matsushima; Y Naribayashi; H Nakata; A Nakamura; T Chiba
Journal:  Intern Med       Date:  1994-04       Impact factor: 1.271

5.  Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis.

Authors:  J S Adams; M A Gacad
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.